Specific VEGF sequestering to biomaterials: Influence of serum stability

Acta Biomaterialia

Volumn 9, Issue 11, 2013, Pages 8823-8831

  Belair, David G ^a   Murphy, William L ^a,b  

^a University of Wisconsin Health   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Angiogenesis; Extracellular matrix; Poly(ethylene glycol); Sequestration; VEGF

Indexed keywords

BLOOD VESSELS; BODY FLUIDS; CELL CULTURE; CELL ENGINEERING; CELL PROLIFERATION; ENDOTHELIAL CELLS; ETHYLENE GLYCOL; MICROSPHERES; PEPTIDES; POLYOLS;

ANGIOGENESIS; CELL BEHAVIOURS; ENDOTHELIAL CELL PROLIFERATION; ENDOTHELIAL-CELLS; EXTRACELLULAR MATRICES; GROWTH FACTOR; SEQUESTRATION; SERUM STABILITY; VASCULAR ENDOTHELIAL GROWTH FACTOR; WOUND HEALING;

POLYETHYLENE GLYCOLS;

BIOMATERIAL; HEPARIN; MACROGOL; MICROSPHERE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ARTICLE; BINDING AFFINITY; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN IMMOBILIZATION; PROTEIN STABILITY; UMBILICAL VEIN ENDOTHELIAL CELL; WILD TYPE;

ANGIOGENESIS; EXTRACELLULAR MATRIX; POLY(ETHYLENE GLYCOL); SEQUESTRATION; VEGF;

BIOCOMPATIBLE MATERIALS; CELL PROLIFERATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICROSPHERES; NORBORNANES; PEPTIDE HYDROLASES; PEPTIDES; POLYETHYLENE GLYCOLS; PROTEIN BINDING; SERUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84885039602     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2013.06.033     Document Type: Article

References (58)

1. P. Bao, A. Kodra, M. Tomic-Canic, M.S. Golinko, H.P. Ehrlich, and H. Brem The role of vascular endothelial growth factor in wound healing J Surg Res 153 2009 347
2. G.L. Semenza Angiogenesis in ischemic and neoplastic disorders Annu Rev Med 54 2003 17
3. P. Carmeliet Mechanisms of angiogenesis and arteriogenesis Nat Med 6 2000 389
4. C.R. Ozawa, A. Banfi, N.L. Glazer, G. Thurston, M.L. Springer, and P.E. Kraft Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis J Clin Invest 113 2004 516
5. S. Barrientos, O. Stojadinovic, M.S. Golinko, H. Brem, and M. Tomic-Canic Growth factors and cytokines in wound healing Wound Repair Regen 16 2008 585
6. Q. Sun, R.R. Chen, Y. Shen, D.J. Mooney, S. Rajagopalan, and P.M. Grossman Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb Pharm Res 22 2005 1110
7. N. Nagai, N. Kumasaka, T. Kawashima, H. Kaji, M. Nishizawa, and T. Abe Preparation and characterization of collagen microspheres for sustained release of VEGF J Mater Sci 21 2010 1891
8. T.R. Chan, P.J. Stahl, and S.M. Yu Matrix-Bound VEGF Mimetic Peptides: Design and Endothelial-Cell Activation in Collagen Scaffolds Adv Funct Mater 21 2011 4252
9. A.Y. Wang, S. Leong, Y.-C. Liang, R.C.C. Huang, C.S. Chen, and S.M. Yu Immobilization of growth factors on collagen scaffolds mediated by polyanionic collagen mimetic peptides and its effect on endothelial cell morphogenesis Biomacromolecules 9 2008 2929
10. M.W. Mosesson Fibrinogen and fibrin structure and functions J Thromb Haemost 3 2005 1894
11. T.-Y. Lee, J. Folkman, and K. Javaherian HSPG-binding peptide corresponding to the exon 6a-encoded domain of VEGF inhibits tumor growth by blocking angiogenesis in murine model PLoS One 5 2010 e9945
12. N. Ferrara Binding to the Extracellular Matrix and Proteolytic Processing: Two Key Mechanisms Regulating Vascular Endothelial Growth Factor Action Mol Biol Cell 21 2010 687
13. Q. Tan, H. Tang, J. Hu, Y. Hu, X. Zhou, and Y. Tao Controlled release of chitosan/heparin nanoparticle-delivered VEGF enhances regeneration of decellularized tissue-engineered scaffolds Int J Nanomed 6 2011 929
14. H.J. Chung, H.K. Kim, J.J. Yoon, and T.G. Park Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery Pharm Res 23 2006 1835
15. Y.-I. Chung, S.-K. Kim, Y.-K. Lee, S.-J. Park, K.-O. Cho, and S.H. Yuk Efficient revascularization by VEGF administration via heparin-functionalized nanoparticle-fibrin complex J Controlled Release 143 2010 282
16. C. Wong, E. Inman, R. Spaethe, and S. Helgerson New Technologies and Diagnostic Tools Fibrin-based biomaterials to deliver human growth factors Thromb Haemostasis 89 2003 573
17. S.H. Kim, and K.L. Kiick Heparin-mimetic sulfated peptides with modulated affinities for heparin-binding peptides and growth factors Peptides 28 2007 2125
18. A.H. Zisch, M.P. Lutolf, and J.A. Hubbell Biopolymeric delivery matrices for angiogenic growth factors Cardiovasc Pathol 12 2003 295
19. H.S. Yang, J. Shin, S.H. Bhang, J.Y. Shin, J. Park, and G.I. Im Enhanced skin wound healing by a sustained release of growth factors contained in platelet-rich plasma Exp Mol Med 43 2011 622
20. R. Elia, P.W. Fuegy, A. VanDelden, M.A. Firpo, G.D. Prestwich, and R.A. Peattie Stimulation of in vivo angiogenesis by in situ crosslinked, dual growth factor-loaded, glycosaminoglycan hydrogels Biomaterials 31 2010 4630
21. G.A. Hudalla, N.A. Kouris, J.T. Koepsel, B.M. Ogle, and W.L. Murphy Harnessing endogenous growth factor activity modulates stem cell behavior Integr Biol 3 2011 832
22. M.W. Toepke, N.A. Impellitteri, S.K. Lan Levengood, D.S. Boeldt, I.M. Bird, and W.L. Murphy Regulating Specific Growth Factor Signaling Using Immobilized Branched Ligands Adv Healthcare Mater 1 2012 457
23. N.A. Impellitteri, M.W. Toepke, S.K. Lan Levengood, and W.L. Murphy Specific VEGF sequestering and release using peptide-functionalized hydrogel microspheres Biomaterials 33 2012 3475
24. X. Zheng, H. Baker, W.S. Hancock, F. Fawaz, M. McCaman, and E. Pungor Proteomic Analysis for the Assessment of Different Lots of Fetal Bovine Serum as a Raw Material for Cell Culture. Part IV. Application of Proteomics to the Manufacture of Biological Drugs Biotechnol Prog 22 2006 1294
25. H.J. Issaq, Z. Xiao, and T.D. Veenstra Serum and plasma proteomics Chem Rev 107 2007 3601
26. C. Piossek, J. Schneider-Mergener, M. Schirner, E. Vakalopoulou, L. Germeroth, and K.H. Thierauch Vascular endothelial growth factor (VEGF) receptor II-derived peptides inhibit VEGF J Biol Chem 274 1999 5612
27. L. Germeroth, C. Piossek, K.-H. Thierauch, J. Schneider-Mergener, R. Volkmer-Engert, and M.F. Bachmann Potent inhibition of angiogenesis by D,L-peptides derived from vascular endothelial growth factor receptor 2 Thromb Haemost 2003 501
28. C.-C. Lin, and K.S. Anseth Controlling Affinity Binding with Peptide-Functionalized Poly(ethylene glycol) Hydrogels Adv Funct Mater 19 2009 2325
29. O. Franssen, and W.E. Hennink A novel preparation method for polymeric microparticles without the use of organic solvents Int J Pharm 168 1998 1
30. N. Ferrara, and W.J. Henzel Pituitary Follicular Cells Secrete a Novel Heparin-Binding Growth Factor Specific for Vascular Endothelial Cells Biochem Biophys Res Commun 161 1989 851
31. T.R. Howdieshell, C. Riegner, V. Gupta, D. Callaway, K. Grembowicz, and Sathyanarayana Normoxic wound fluid contains high levels of vascular endothelial growth factor Ann Surg 228 1998 707
32. L. Michaelis, and M.L. Menten Die kinetik der invertinwirkung Biochem Z 49 1913 352
33. I.M. Klotz, and R. Rosenberg Chemical thermodynamics 5th ed. 1994 John Wiley & Sons New York
34. S. Cooper Reappraisal of serum starvation, the restriction point, G0, and G1 phase arrest points FASEB J 17 2003 333
35. C.F. Welsh, K. Roovers, J. Villanueva, Y. Liu, M.A. Schwartz, and R.K. Assoian Timing of cyclin D1 expression within G1 phase is controlled by Rho Nat Cell Biol 3 2001 950
36. A.S.R. Maharaj, and P.A. D'Amore Roles for VEGF in the adult Microvasc Res 74 2007 100
37. S. Serratì, F. Margheri, M. Pucci, A.R. Cantelmo, R. Cammarota, and J. Dotor TGFbeta1 antagonistic peptides inhibit TGFbeta1-dependent angiogenesis Biochem Pharmacol 77 2009 813
38. P.S. Bhattacharjee, T.S. Huq, T.K. Mandal, R.A. Graves, S. Muniruzzaman, and C. Clement A novel peptide derived from human apolipoprotein E is an inhibitor of tumor growth and ocular angiogenesis PLoS One 6 2011 e15905
39. K. Vulic, and M.S. Shoichet Tunable growth factor delivery from injectable hydrogels for tissue engineering J Am Chem Soc 134 2012 882
40. L. Zhang, E.M. Furst, and K.L. Kiick Manipulation of hydrogel assembly and growth factor delivery via the use of peptide-polysaccharide interactions J Control Release 114 2006 130
41. S.M. Willerth, P.J. Johnson, D.J. Maxwell, S.R. Parsons, M.E. Doukas, and S.E. Sakiyama-elbert Rationally designed peptides for controlled release of nerve growth factor from fibrin matrices J Biomed Mater Res, Part A 80 2006 13
42. H. Hosseinkhani, M. Hosseinkhani, A. Khademhosseini, H. Kobayashi, and Y. Tabata Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration Biomaterials 27 2006 5836
43. H. Engelberg, and A. Dudley Plasma Heparin Levels in Normal Man Circulation 23 1961 578
44. K. Hofmann-Kiefer, G. Kemming, D. Chappell, M. Flondor, H. Kisch-Wedel, and A. Hauser Serum Heparan Sulfate Levels are Elevated in Endotoxemia Eur J Med Res 14 2009 526
45. H. Yokoyama, K. Sato, M. Okudaira, C. Morita, C. Takahashi, and D. Suzuki Serum and urinary concentrations of heparan sulfate in patients with diabetic nephropathy Kidney Int 56 1999 650
46. S. Tesslers, P. Rockwell, D. Hicklinb, T. Cohenln, B. Levin, and L. Witte Heparin Modulates the Interaction of VEGF, with Soluble and Cell Associated flk-1 Receptors* J Biol Chem 269 1994 12456
47. H. Gitay-Goren, S. Soker, I. Vlodavsky, and G. Neufeld The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules J Biol Chem 267 1992 6093
48. S. Soker, D. Goldstaub, C.M. Svahn, I. Vlodavsky, B.-Z. Levi, and G. Neufeld Variations in the size and sulfation of heparin modulate the effect of heparin on the binding of VEGF165 to its receptors Biochem Biophys Res Commun 203 1994 1339
49. W.J. Fairbrother, H.W. Christinger, A.G. Cochran, G. Fu, C.J. Keenan, and C. Quan Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site Biochemistry 37 1998 17754
50. M. Héroult, I. Bernard-Pierrot, J. Delbé, Y. Hamma-Kourbali, P. Katsoris, and D. Barritault Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis Oncogene 23 2004 1745
51. N. Papo, A.P. Silverman, J.L. Lahti, and J.R. Cochran Antagonistic VEGF variants engineered to simultaneously bind to and inhibit VEGFR2 and alphavbeta3 integrin Proc Natl Acad Sci U S A 108 2011 14067
52. D.G. Udugamasooriya, S.P. Dineen, R.A. Brekken, and T. Kodadek A peptoid "antibody surrogate" that antagonizes VEGF receptor 2 activity J Am Chem Soc 130 2008 5744
53. L. Hetian, A. Ping, S. Shumei, L. Xiaoying, H. Luowen, and W. Jian A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor J Biol Chem 277 2002 43137
54. J.T. Koepsel, E.H. Nguyen, and W.L. Murphy Differential effects of a soluble or immobilized VEGFR-binding peptide Integr Biol 4 2012 914
55. M.F. Powell, H. Grey, F. Gaeta, A. Sette, and S. Colon Peptide Stability in Drug Development: A Comparison of Peptide Reactivity in Different Biological Media J Pharm Sci 81 1992 731
56. S.Y. Hong, J.E. Oh, K.-H. Lee, and M. Peptide Effect of D -Amino Acid Substitution on the Stability, the Secondary Structure, and the Activity of Membrane-Active Peptide Biochem Pharmacol 58 1999 1775
57. M. Powell, T. Stewart, L. Otvos, L. Urge, F.C.A. Gaeta, and A. Sette Peptide Stability in Drug Development: Effect of Single Amino-Acid Substitution and Glycosylation on Peptide Reactivity in Human Serum Pharm Res 10 1993 1268
58. J.R. Walker, R.K. Altman, J.W. Warren, and E. Altman Using protein-based motifs to stabilize peptides J Pept Res 62 2003 214